Related Experiment Videos
Pervanadate inhibits mitogen-activated protein kinase kinase-1 in a p38MAPK-dependent manner
1Department of Surgery, University of Washington, Seattle 98195-6410, USA. daum@u.washington.edu
Abstract:
In baboon smooth muscle cells (SMCs), pervanadate has a biphasic dose-dependent effect on MEK-1 activity. After a 30 min incubation period, low concentrations (1-10 microM) activate, while higher doses (30-100 microM) fail to stimulate MEK-1. One possibility is that higher doses of pervanadate induce an additional signaling pathway that inhibits MEK-1. Three lines of investigations provide support for the conclusion that this inhibitory effect is mediated by p38MAPK. First, pervanadate induces p38MAPK activity at concentrations that fail to activate MEK-1. Second, pervanadate-stimulated p38MAPK activity is maximal after a 10 min incubation, at a time, when MEK-1 activity disappears. Third, addition of the specific p38MAPK inhibitor SB203580 preserves MEK-1 activation by 100 microM pervanadate. The inhibitory effect of p38MAPK is probably not due to a phosphorylation of MEK-1 although we can not rule out that other p38MAPK isoforms such as SAPK3 and SAPK4 may be involved, and may directly phosphorylate and inhibit MEK-1.
Insights
Pervanadate affects smooth muscle cell MEK-1 activity differently based on dose. Higher doses inhibit MEK-1, likely through p38 mitogen-activated protein kinase (MAPK) signaling.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Biochemistry
Background:
- Pervanadate exhibits a biphasic dose-dependent effect on MEK-1 activity in baboon smooth muscle cells (SMCs).
- Low pervanadate concentrations (1-10 microM) activate MEK-1, while higher concentrations (30-100 microM) do not.
- This suggests a potential inhibitory signaling pathway activated by higher pervanadate doses.
Purpose of the Study:
- To investigate the mechanism behind pervanadate-induced inhibition of MEK-1 activity in SMCs.
- To determine if p38 mitogen-activated protein kinase (p38MAPK) mediates this inhibitory effect.
Main Methods:
- Treatment of baboon SMCs with varying concentrations of pervanadate.
- Measurement of MEK-1 and p38MAPK activity over time.
- Utilizing the specific p38MAPK inhibitor SB203580 to assess its impact on MEK-1 activation.
Main Results:
- Pervanadate induced p38MAPK activity at concentrations that failed to activate MEK-1.
- p38MAPK activity peaked at 10 minutes, coinciding with the disappearance of MEK-1 activity.
- Inhibition of p38MAPK with SB203580 restored MEK-1 activation by high-dose pervanadate.
- The inhibitory mechanism may not involve direct MEK-1 phosphorylation, but other p38MAPK isoforms could be involved.
Conclusions:
- The inhibitory effect of high-dose pervanadate on MEK-1 in SMCs is mediated by p38MAPK.
- p38MAPK activation by pervanadate plays a crucial role in regulating MEK-1 activity.
- Further research is needed to elucidate the precise molecular interactions between p38MAPK and MEK-1.